Syngene International Ltd - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring peer group for Syngene International Ltd are shown below. Browse to the end of the webpage for potential risks for Syngene International Ltd based on industry, location and size. Full Sustainability analysis of Syngene International Ltd can be reached by registering for free.
Syngene International Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Syngene International Ltd | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Syngene International Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Syngene International Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Syngene International Ltd report the average age of the workforce?
Sign up for free to unlockDoes Syngene International Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Syngene International Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Syngene International Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Syngene International Ltd offer flexible work?
Sign up for free to unlockDoes Syngene International Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Syngene International Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Syngene International Ltd conduct supply chain audits?
Sign up for free to unlockDoes Syngene International Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Syngene International Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Syngene International Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Syngene International Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Syngene International Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Syngene International Ltd disclose water use targets?
Sign up for free to unlockDoes Syngene International Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Syngene International Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Syngene International Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Syngene International Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Syngene International Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Syngene International Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Syngene International Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Syngene International Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Syngene International Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Syngene International Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Syngene International Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Syngene International Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Syngene International Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Syngene International Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Syngene International Ltd disclose its waste policy?
Sign up for free to unlockDoes Syngene International Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Syngene International Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Syngene International Ltd disclose energy use targets?
Sign up for free to unlockDoes Syngene International Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Syngene International Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Syngene International Ltd
These potential risks are based on the size, segment and geographies of the company.
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it offers other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter Inc.; and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.